Interplay between circadian and reward pathways in homeostatic response and pathology
昼夜节律和奖励途径在稳态反应和病理学中的相互作用
基本信息
- 批准号:10656214
- 负责人:
- 金额:$ 39.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease patientAmericanAstronomyBehaviorBiological ProcessCircadian RhythmsCircadian desynchronyCuesDietDopamine ReceptorDopaminergic CellEventExerciseFoodFood AccessGenetic TranscriptionGoalsHealthHealthcare SystemsHourHumanHypothalamic structureLaboratoriesLightLightingMetabolicMetabolic DiseasesMetabolic dysfunctionMidbrain structureModernizationMolecularNeurodegenerative DisordersNeuronsObesityPathologyPathway interactionsPeriodicityPersonsPhysiologicalPhysiologyPrevalencePublic HealthRecurrenceRewardsSignal TransductionSocial InteractionSocietiesStressTarget PopulationsTimeWeight GainWorkadverse outcomebehavioral responsecircadiancircadian pacemakerdopaminergic neuronfood consumptionfood restrictionhigh riskinsightmouse modelneural circuitneuronal circuitrynovelpressurereduce symptomsresponsesuprachiasmatic nucleustherapeutic target
项目摘要
Project Summary: Biological processes ranging from gene transcription to behavior oscillate and are
synchronized to the 24-hour day/night cycle. Mammalian circadian rhythms, orchestrated by the hypothalamic
suprachiasmatic nucleus (SCN) allow appropriately timed physiological and behavioral responses to daily
recurring external cues (i.e. sunrise or timed meal availability). The resulting synchrony of physiology to the
astronomical day maximizes metabolic efficiency and good health. However, many of the stresses of modern
society (i.e. artificial lighting and omnipresence of food) weaken and desynchronize circadian rhythms. This in
turn increases the prevalence of many pathologies including metabolic disorders and neurodegenerative
diseases. The aim of my laboratory is to determine how circadian rhythms are synchronized to external cues
(circadian entrainment) and how desynchronization impacts health. Although the neuronal pathways of light-
driven entrainment are well-established, how other external cues, such as food availability, social interactions or
exercise, influence the workings of the SCN remains unknown. In a recent breakthrough, we identified a neuronal
connection between midbrain dopaminergic neurons that are activated in response to salient events and SCN
neurons that express the dopamine receptor Drd1. We showed that this pathway accelerates photoentrainment
and drives palatable food consumption outside of mealtimes. In parallel, we identified a novel molecular player
that is necessary for anticipation-related activity to time-restricted food access. Here, we propose to leverage
our expertise in disentangling circadian entrainment neurocircuitry to delineate the mechanisms by which
rewarding cues modulate the SCN circadian clock. Furthermore, we will determine whether strengthening
circadian rhythmicity ameliorates symptoms of neurodegenerative diseases. Our first objective is to gain a
mechanistic understanding of how salient events impact SCN activity and circadian entrainment. We hypothesize
that activation of dopaminergic signaling decreases the amplitude of SCN oscillation and allows faster
photoentrainment. This novel insight will be useful to develop strategies to curb the negative impact of circadian
desynchrony. Our second goal is to identify the midbrain dopaminergic cell population that targets the SCN and
promotes palatable food consumption outside of meal times, leading to weight gain and metabolic disorder. We
predict that by mimicking dopaminergic signaling in the SCN, we will control food consumption. Delineating this
pathway will provide therapeutic targets against diet induced metabolic dysfunction and obesity. Our final
objective is to determine if high amplitude circadian rhythms, by daily consolidation of light and food access, is
sufficient to slow the progression of a mouse model of Alzheimer’s disease (AD). If successful, entrainment
strategies will become potential treatments for AD patients and people with high-risk of developing AD. We
expect our work will provide a better understanding of the relationship between entrainment cues, physiology
and behavior while providing tangible strategies against the adverse consequences of circadian misalignment.
项目摘要:从基因转录到行为振荡的生物过程
与下丘脑协调的 24 小时昼夜节律同步。
视交叉上核 (SCN) 允许对日常生理和行为做出适当的定时反应
反复出现的外部线索(即日出或定时进餐)所产生的生理学同步性。
天文日最大限度地提高新陈代谢效率和良好的健康然而,现代人的许多压力。
社会(即人工照明和无处不在的食物)削弱了昼夜节律并使之不同步。
反过来增加了许多疾病的患病率,包括代谢紊乱和神经退行性疾病
我实验室的目的是确定昼夜节律如何与外部线索同步。
(昼夜节律夹带)以及去同步如何影响健康。
驱动夹带是既定的,其他外部线索,如食物供应、社交互动或
运动对 SCN 运作的影响仍然未知。在最近的一项突破中,我们发现了一个神经元。
响应显着事件而激活的中脑多巴胺能神经元与 SCN 之间的连接
我们发现,表达多巴胺受体 Drd1 的神经元可以加速光诱导作用。
同时,我们发现了一种新的分子因素。
这对于与时间限制的食物获取有关的预期活动是必要的。在这里,我们建议利用这一点。
我们在解开昼夜节律神经回路方面的专业知识,以描述其机制
此外,奖励线索调节 SCN 生物钟,我们将确定是否加强。
昼夜节律可以改善神经退行性疾病的症状。
对显着事件如何影响 SCN 活动和昼夜节律夹带的机械理解。
多巴胺能信号的激活降低了 SCN 振荡的幅度并允许更快
这种新颖的见解将有助于制定遏制昼夜节律负面影响的策略。
我们的第二个目标是确定针对 SCN 和的中脑多巴胺能细胞群。
促进在用餐时间之外食用可口的食物,导致体重增加和代谢紊乱。
预测通过模仿 SCN 中的多巴胺能信号,我们将控制食物消耗。
我们的最终途径将为饮食引起的代谢功能障碍和肥胖提供治疗靶点。
目的是通过每日巩固光照和食物获取来确定高振幅昼夜节律是否有效
如果成功的话,足以减缓阿尔茨海默病(AD)小鼠模型的进展。
策略将成为 AD 患者和 AD 高危人群的潜在治疗方法。
期望我们的工作能够更好地理解夹带线索、生理学之间的关系
和行为,同时提供切实的策略来应对昼夜节律失调的不利后果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ali Guler其他文献
Ali Guler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ali Guler', 18)}}的其他基金
Interplay between circadian and reward pathways in homeostatic response and pathology
昼夜节律和奖励途径在稳态反应和病理学中的相互作用
- 批准号:
10437612 - 财政年份:2021
- 资助金额:
$ 39.87万 - 项目类别:
Interplay between circadian and reward pathways in homeostatic response and pathology
昼夜节律和奖励途径在稳态反应和病理学中的相互作用
- 批准号:
10166690 - 财政年份:2021
- 资助金额:
$ 39.87万 - 项目类别:
Interplay between circadian and reward pathways in homeostatic response and pathology
昼夜节律和奖励途径在稳态反应和病理学中的相互作用
- 批准号:
10793158 - 财政年份:2021
- 资助金额:
$ 39.87万 - 项目类别:
Interplay between circadian and reward pathways in homeostatic response and pathology
昼夜节律和奖励途径在稳态反应和病理学中的相互作用
- 批准号:
10580516 - 财政年份:2021
- 资助金额:
$ 39.87万 - 项目类别:
Regulation of central circadian rhythms by dopamine
多巴胺调节中央昼夜节律
- 批准号:
9338266 - 财政年份:2016
- 资助金额:
$ 39.87万 - 项目类别:
Regulation of central circadian rhythms by dopamine
多巴胺调节中央昼夜节律
- 批准号:
10004681 - 财政年份:2016
- 资助金额:
$ 39.87万 - 项目类别:
Regulation of central circadian rhythms by dopamine
多巴胺调节中央昼夜节律
- 批准号:
9193742 - 财政年份:2016
- 资助金额:
$ 39.87万 - 项目类别:
相似国自然基金
基于神经退行性疾病前瞻性队列的新烟碱类杀虫剂暴露对阿尔茨海默病的影响及作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
基于miRNA介导ceRNA网络调控作用的防治阿尔茨海默病及认知障碍相关疾病药物的发现研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
LMTK1调控核内体转运介导阿尔茨海默病神经元Reserve机制研究
- 批准号:81903703
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于自组装多肽纳米探针检测蛋白标志物用于阿尔茨海默病精准诊断的研究
- 批准号:31900984
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
靶向干预CD33/Aβ相互作用改善小胶质细胞功能延缓AD病理进程
- 批准号:81901072
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 39.87万 - 项目类别:
Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations
多种族人群中 AD 的中心连锁纵向外周生物标志物
- 批准号:
10555723 - 财政年份:2023
- 资助金额:
$ 39.87万 - 项目类别:
Impact of Mitochondrial Lipidomic Dynamics and its Interaction with APOE Isoforms on Brain Aging and Alzheimers Disease
线粒体脂质组动力学及其与 APOE 亚型的相互作用对脑衰老和阿尔茨海默病的影响
- 批准号:
10645610 - 财政年份:2023
- 资助金额:
$ 39.87万 - 项目类别:
Developing a nonpharmacological pain intervention for community dwelling older adults with dementia
为社区居住的痴呆症老年人开发非药物疼痛干预措施
- 批准号:
10644490 - 财政年份:2023
- 资助金额:
$ 39.87万 - 项目类别: